Transcriptional regulators of iris muscle cell development
Transcriptional regulators of iris muscle cell development
批准号:
9895360
负责人:
Timothy A. Blenkinsop
金额:
$25.3万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31
关键词:
AdultAge related macular degenerationBMP4BMP7 geneBindingBlindnessCRISPR/Cas technologyCadaverCell Differentiation processCellsCytokine SignalingDataDevelopmentDiseaseEventEyeEye DevelopmentEye diseasesFosteringFutureGene ExpressionGenesGenetic TranscriptionGenomicsGerm LayersGoalsGrantHealthHumanImageImmunofluorescence ImmunologicInflammatoryIrisKnock-outKnockout MiceKnowledgeLeadMacular degenerationMembraneMesodermMissionModelingMuscleMuscle CellsMuscle DevelopmentMutationMyoblastsNeural CrestNeural Tube DevelopmentNeural tubeNeuroectodermNeurogliaOrganoidsOutcomePathologicPatientsPericytesPhenotypePlayPopulationPreventionPrimary Open Angle GlaucomaProcessProliferative VitreoretinopathyProtocols documentationPublic HealthRNAResearchResearch ProposalsRetinaRetinal DetachmentRiskRoleSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesSourceSpecific qualifier valueStructureStructure of retinal pigment epitheliumSystemTNF geneTechniquesTestingTimeTissuesTransforming Growth Factor betaUnited States National Institutes of HealthVisual FieldsWestern BlottingWorkZebrafishcell fate specificationcytokineexperimental studygene inductiongenetic signatureimprovedinhibitor/antagonistinnovationinsightknock-downnovelolfactomedinoptic cupoverexpressionpreventprogramsproliferative diabetic retinopathypublic health relevancesingle-cell RNA sequencingtherapy developmenttranscriptome sequencing
中文摘要
项目摘要
虹膜肌肉是神经管衍生肌肉的一个罕见的例子,令人惊讶的是,很少有人知道这是如何发生的。
显着打破了胚层规则。虽然我们知道PAX 6表达在虹膜肌肉中起作用,
说明和ACTA 2存在,虹膜肌细胞如何在视杯尖端被指定尚不清楚。
长期目标是了解激活肌肉命运程序的信号事件,
开发光学杯。这种命运决定的顺序使得这种罕见的肌肉分化的例子
从发展神经管的过程中,这是本建议打算审查和本建议的目标。
我们预测许多平滑肌细胞分化所需的候选细胞将参与其中,但
将是虹膜肌肉发展所必需的独特过程,这是独一无二的,由于它们的规格来自
神经管而不是神经嵴或中胚层。当受到炎性细胞因子刺激时,
尽管在病理学上在疾病如炎症性玻璃体视网膜病变中
(PVR)糖尿病性视网膜病变、视网膜病变相关性黄斑变性、黄斑皱褶等。成人
人RPE(ahRPE)、视网膜神经胶质细胞和视网膜周细胞表达收缩装置,导致视网膜细胞收缩。
肌收缩膜的发展,其在收缩时引起视网膜脱离和视力丧失。
核心假设是视网膜转分化成肌肉表型的能力来源于视网膜的细胞分化。
与虹膜肌有共同的发育起源。这一建议背后的理性是:虹膜肌肉
虹膜的发育并不为人所知,了解虹膜肌肉的发育可能会提供对虹膜如何发育的深入了解。
视网膜在眼病中发育成可收缩的膜。中心假设将通过以下方式进行检验:
这些具体目的:1)检测患者中是否存在肌肉相关基因OLFM 2和MYOCD,
解剖的收缩膜对于眼类器官模型中的虹膜肌分化是必需的。2)到
通过单细胞比较成人虹膜肌基因签名与人眼类器官表达
RNA测序3)通过评估现有KO小鼠确认OLFM 2和MYOCD的作用。虹膜肌肉
在视杯的尖端处区分,具有RPE的连续双层,从神经管发育而来。我们将
利用分析和实验技术的创新组合来实现这些目标。这些包括
使用我们先前建立的方案,从人成人尸体组织中分离RNA,
存活率和产量以实现单细胞RNA-seq。此外,我们已经开发了一种眼类器官分化
第一个产生假定虹膜肌肉细胞的协议。这项研究计划意义重大,因为
结果将开始描述参与虹膜肌肉发育的因素,
眼部疾病中的收缩膜形成。这项工作的预期成果是一个更完整的
了解神经外胚层衍生的肌肉特化和收缩膜形成。结果
将产生积极的影响,因为获得的新见解将为预防视力丧失指出新的目标。
英文摘要
Project Summary
Iris muscle is a rare example of a neural tube derived muscle and surprisingly little is known how this
remarkable break in germ layer rules is carried out. While we know PAX6 expression plays a role in iris muscle
specification and that ACTA2 is present, how iris muscle cells are specified at the optic cup tip is not known.
The long-term goal is to understand the signaling events that activate the muscle fate program from the
developing optic cup. The sequence of fate decisions that enable this rare example of muscle differentiation
from developing neural tube is the process this proposal intends to examine and the objective of this proposal.
We predict many of the candidates necessary for smooth muscle cell differentiation will be involved, but there
will be distinct processes necessary for iris muscle to develop that is unique, due to their specification from the
neural tube instead of neural crest or mesoderm. The retina when stimulated with inflammatory cytokines
differentiates towards muscle cell fate, albeit pathologically in diseases such as Proliferative Vitreoretinopathy
(PVR), Proliferative Diabetic Retinopathy, Age-related Macular Degeneration Macular Pucker and more. Adult
human RPE (ahRPE), retinal glia and retinal pericytes express contraction apparatus, leading to the
development of myocontractile membranes, which upon contraction, cause retinal detachment and vision loss.
The central hypothesis is the ability of the retina to transdifferentiate into a muscle phenotype originates from
having a shared developmental origin with the iris muscle. The rational underlying this proposal is: iris muscle
development is not well known and understanding iris muscle development may provide insight into how the
retina develops into contractile membranes in eye diseases. The central hypothesis will be tested by pursuing
these Specific Aims: 1) To test whether muscle associated genes OLFM2 and MYOCD identified in patient
dissected contractile membranes are necessary for iris muscle differentiation in an eye organoid model. 2) To
compare the adult human iris muscle gene signature with expression of human eye organoids by single cell
RNA-seq. 3) To confirm role of OLFM2 and MYOCD by evaluating existing KO mice. The iris muscle
differentiates at the tip of the optic cup, a continuous bilayer with RPE, developed from the neural tube. We will
pursue these aims using an innovative combination of analytical and experimental techniques. These includes
using our previously established protocol to isolated RNA from human adult cadaver tissue with sufficient
survival and yield to enable single cell RNA-seq. Moreover, we have developed an eye organoid differentiation
protocol that generates presumptive iris muscle cells, a first. The research proposal is significant, because the
results will begin to describe factors participating iris muscle development and we will gain insight into
contractile membrane formation in eye disease. The expected outcome of this work is a more complete
understanding of neuroectoderm derived muscle specification and contractile membrane formation. The results
will have a positive impact as the new insight gained will point to new targets for the prevention of vision loss.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reversing Contractility in Epiretinal Membranes
-
批准号:9886929
-
项目类别:
-
资助金额:$40.86万
-
财政年份:2020
-
负责人:Timothy A. Blenkinsop
-
依托单位:
Transcriptional regulators of iris muscle cell development
-
批准号:10077562
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2020
-
负责人:Timothy A. Blenkinsop
-
依托单位:
Reversing Contractility in Epiretinal Membranes
-
批准号:10382319
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2020
-
负责人:Timothy A. Blenkinsop
-
依托单位:
Reversing Contractility in Epiretinal Membranes
-
批准号:10608051
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2020
-
负责人:Timothy A. Blenkinsop
-
依托单位:
Reversing Contractility in Epiretinal Membranes
-
批准号:10170360
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2020
-
负责人:Timothy A. Blenkinsop
-
依托单位:
海外基金